U.S. Heightens Scrutiny of India's Drug Makers ; Rush of Counterfeiting and Wave of Safety Lapses Threaten Major Industry

By Harris, Gardiner | International New York Times, February 17, 2014 | Go to article overview

U.S. Heightens Scrutiny of India's Drug Makers ; Rush of Counterfeiting and Wave of Safety Lapses Threaten Major Industry


Harris, Gardiner, International New York Times


American regulators are looking into instances of safety lapses, falsified drug test results and the sale of fake medicines.

India, one of the largest exporters of over-the-counter and prescription drugs to the United States, is coming under increased scrutiny by American regulators for safety lapses, falsified drug test results and the sale of fake medicines.

Margaret A. Hamburg, the commissioner of the United States Food and Drug Administration, arrived in India last week to express her growing unease with the safety of Indian medicines because of "recent lapses in quality at a handful of pharmaceutical firms."

India's pharmaceutical industry supplies 40 percent of over-the- counter and generic prescription drugs consumed in the United States, so the increased scrutiny could have profound implications for those consumers.

F.D.A. investigators have been blitzing Indian drug plants, financing the inspections with some of the roughly $300 million in annual fees from generic drug makers collected as part of a 2012 law requiring increased scrutiny of overseas plants. The agency inspected 160 Indian drug plants last year, three times as many as in 2009. The increased scrutiny has led to a flood of new penalties, including half of the warning letters the agency issued last year to drug makers.

Dr. Hamburg was met by Indian officials and executives who have been shocked by F.D.A. export bans on generic versions of popular medicines -- the acne drug Accutane, for example, the pain-reducing drug Neurontin and the antibiotic Cipro -- that the F.D.A. determined were adulterated. The officials said they suspected she was protecting a domestic industry from cheaper imports.

"There are some people who take a very sinister view of the F.D.A. inspections," Keshav Desiraju, India's health secretary until last week, said in an interview.

The F.D.A.'s increased enforcement has already cost Indian companies dearly. Ranbaxy, one of India's biggest drug manufacturers, pleaded guilty to felony charges and paid a $500 million fine last year, the largest ever levied against a generic- drug company. Many companies worry that worse is in store.

"If I have to follow U.S. standards in inspecting facilities supplying to the Indian market," G.N. Singh, India's top drug regulator, said in an interview with an Indian newspaper, "we will have to shut almost all of those."

A top executive at Ranbaxy pleaded with Dr. Hamburg at a meeting last Tuesday with other drug executives that his products be allowed into the United States so the company could more easily pay for fixes and improvements. Ranbaxy has been caught lying to the F.D.A. on several occasions and found to have conditions such as flies "too numerous to count" in critical plant areas. Dr. Hamburg politely declined.

The drug industry is one of India's most important economic engines, exporting $15 billion in products annually, and some of its factories are world-class, virtually undistinguishable from their counterparts in the West. But others suffer from serious quality control problems. The World Health Organization estimates that one in five drugs made in India is fake. A 2010 survey of Delhi pharmacies found that 12 percent of sampled drugs were counterfeit.

In one example, fake medicines at a pediatric hospital in Kashmir are suspected of playing a role in hundreds of infant deaths there in recent years. One widely used antibiotic was found to contain no active ingredient after being randomly tested in a government lab. The test was kept secret for nearly a year while about 100,000 useless pills continued to be dispensed. More tests of hospital medicines found dozens more that were substandard, including a crucial intravenous antibiotic used in sick infants.

"Some of the fake tablets were used by pregnant women in the postsurgical prevention of infections," said M. Ishaq Geer, a senior assistant professor of pharmacology at Kashmir University. …

The rest of this article is only available to active members of Questia

Already a member? Log in now.

Notes for this article

Add a new note
If you are trying to select text to create highlights or citations, remember that you must now click or tap on the first word, and then click or tap on the last word.
One moment ...
Default project is now your active project.
Project items

Items saved from this article

This article has been saved
Highlights (0)
Some of your highlights are legacy items.

Highlights saved before July 30, 2012 will not be displayed on their respective source pages.

You can easily re-create the highlights by opening the book page or article, selecting the text, and clicking “Highlight.”

Citations (0)
Some of your citations are legacy items.

Any citation created before July 30, 2012 will labeled as a “Cited page.” New citations will be saved as cited passages, pages or articles.

We also added the ability to view new citations from your projects or the book or article where you created them.

Notes (0)
Bookmarks (0)

You have no saved items from this article

Project items include:
  • Saved book/article
  • Highlights
  • Quotes/citations
  • Notes
  • Bookmarks
Notes
Cite this article

Cited article

Style
Citations are available only to our active members.
Buy instant access to cite pages or passages in MLA, APA and Chicago citation styles.

(Einhorn, 1992, p. 25)

(Einhorn 25)

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited article

U.S. Heightens Scrutiny of India's Drug Makers ; Rush of Counterfeiting and Wave of Safety Lapses Threaten Major Industry
Settings

Settings

Typeface
Text size Smaller Larger Reset View mode
Search within

Search within this article

Look up

Look up a word

  • Dictionary
  • Thesaurus
Please submit a word or phrase above.
Print this page

Print this page

Why can't I print more than one page at a time?

Help
Full screen

matching results for page

    Questia reader help

    How to highlight and cite specific passages

    1. Click or tap the first word you want to select.
    2. Click or tap the last word you want to select, and you’ll see everything in between get selected.
    3. You’ll then get a menu of options like creating a highlight or a citation from that passage of text.

    OK, got it!

    Cited passage

    Style
    Citations are available only to our active members.
    Buy instant access to cite pages or passages in MLA, APA and Chicago citation styles.

    "Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn, 1992, p. 25).

    "Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn 25)

    "Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences."1

    1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

    Cited passage

    Thanks for trying Questia!

    Please continue trying out our research tools, but please note, full functionality is available only to our active members.

    Your work will be lost once you leave this Web page.

    Buy instant access to save your work.

    Already a member? Log in now.

    Author Advanced search

    Oops!

    An unknown error has occurred. Please click the button below to reload the page. If the problem persists, please try again in a little while.